Trial Profile
Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alteplase (Primary) ; Heparin; Low molecular weight heparins; Warfarin
- Indications Deep vein thrombosis; Peripheral vascular disorders
- Focus Therapeutic Use
- Acronyms PHLO
- 08 Aug 2018 Status changed from not yet recruiting to withdrawn prior to enrolment as trial did not receive NIH Funding
- 18 Sep 2017 Planned End Date changed from 1 Jun 2022 to 1 Jun 2023.
- 18 Sep 2017 Planned primary completion date changed from 1 Apr 2022 to 1 Apr 2023.